{
    "clinical_study": {
        "@rank": "36854", 
        "arm_group": [
            {
                "arm_group_label": "AF expert program", 
                "arm_group_type": "Experimental", 
                "description": "Care provided by the interdisciplinary, nurse-coordinated AF expert program"
            }, 
            {
                "arm_group_label": "Usual care", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the effectiveness of a newly developed\n      interdisciplinary nurse-coordinated AF expert program for primary care patients. Therefore a\n      prospective, pragmatic clustered randomized controlled trial will be performed in general\n      practices."
        }, 
        "brief_title": "Effectiveness of an Interdisciplinary, Nurse-coordinated Atrial Fibrillation Expert Program for Primary Care Patients", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Every newly diagnosed AF patient.\n\n          -  Every AF patient who is not seen by a cardiologist or electrophysiologist in the past\n             2 years before inclusion.\n\n          -  AF must be confirmed on electrocardiogram.\n\n          -  Capable of providing written informed consent.\n\n          -  Dutch speaking and verbally testable, without cognitive impairment.\n\n        Exclusion Criteria:\n\n          -  AF patients who once received an arrhythmologic consult about AF prior to the start\n             of the study.\n\n          -  AF patients who have a systematic follow-up at a cardiologist prior to the start of\n             the study.\n\n          -  Terminally ill AF patients\n\n          -  Participation in another clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "450", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928121", 
            "org_study_id": "not yet applicable"
        }, 
        "intervention": {
            "arm_group_label": "AF expert program", 
            "intervention_name": "Care provided by AF expert program", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "nurse", 
            "expert program", 
            "primary care", 
            "implementation", 
            "interdisciplinary", 
            "effectiveness", 
            "disease management system"
        ], 
        "lastchanged_date": "August 23, 2013", 
        "location": {
            "contact": {
                "email": "dana.berti@uzleuven.be", 
                "last_name": "Dana Berti", 
                "phone": "0032-16-341848"
            }, 
            "contact_backup": {
                "email": "hein.heidbuchel@uzleuven.be", 
                "last_name": "Hein Heidbuchel", 
                "phone": "0032-16-344248"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Vlaams Brabant", 
                    "zip": "3000"
                }, 
                "name": "UZ Leuven"
            }, 
            "investigator": [
                {
                    "last_name": "Dana Berti", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Hein Heidbuchel", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of an Interdisciplinary, Nurse-coordinated Atrial Fibrillation Expert Program for Primary Care Patients - A Clustered Randomized Controlled Trial", 
        "overall_contact": {
            "email": "dana.berti@uzleuven.be", 
            "last_name": "Dana Berti", 
            "phone": "0032-479-845016"
        }, 
        "overall_contact_backup": {
            "email": "hein.heidbuchel@uzleuven.be", 
            "last_name": "Hein Heidbuchel", 
            "phone": "0032-16-344248"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: UZ Leuven Medical Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Combined endpoint of cardiovascular hospitalizations, cardiovascular deaths and unplanned cardiovascular visits.\nCardiac death: Cardiac arrhythmic, Cardiac non-arrhythmic, Vascular non cardiac\nCardiovascular hospitalization: Arrhythmic events (AF, syncope, sustained ventricular tachycardia, cardiac arrest), Heart Failure, Acute myocardial infarction, Stroke, Systemic embolism, Major bleeding, Life-threatening effects of drugs\nUnplanned cardiovascular visits", 
            "measure": "cardiovascular events", 
            "safety_issue": "No", 
            "time_frame": "after 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928121"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universitaire Ziekenhuizen Leuven", 
            "investigator_full_name": "Prof Heidbuchel", 
            "investigator_title": "Prof. Hein Heidbuchel, MD, PHD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Does the medical record report a formal CHA2DS2-VASc score, HAS-BLED bleeding risk score and EHRA score?\nDoes the medical record report an appropriate prescription of antithrombotic treatment.\nDoes the medical record report an appropriate application of rate and rhythm (not if asymptomatic, if contraindicated and not in patients with permanent AF)\nDoes the medical record report an appropriate upstream therapy? (For example in heart failure patients, is the heart failure treated)", 
                "measure": "Guideline adherence", 
                "safety_issue": "No", 
                "time_frame": "after 1 year"
            }, 
            {
                "description": "Number of outpatient (internal or neurological) clinic visits per year\nNumber of emergency room visits per year due to AF\nNumber of hospitalization days due to AF\nNumber of hospitalization days for cardiovascular reasons\nNumber of hospitalization days on intensive care due to AF", 
                "measure": "Hospitalization days and clinic visits", 
                "safety_issue": "No", 
                "time_frame": "after 1 year"
            }, 
            {
                "description": "Perceived health will be measured by the EuroQol Five Dimensional Questionnaire (EQ-5D-3L)", 
                "measure": "Perceived health", 
                "safety_issue": "No", 
                "time_frame": "After 1 year"
            }, 
            {
                "description": "AF related symptoms and symptom burden will be measured by the Leuven Arrhythmia Questionnaire (LARQ)", 
                "measure": "AF related symptoms and symptom burden", 
                "safety_issue": "No", 
                "time_frame": "After 1 year"
            }, 
            {
                "description": "Patient satisfaction about information provided, about therapy and about follow-up, will be measured with a 10-point visual analog scale (VAS).", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "After  year"
            }, 
            {
                "description": "The Atrial Fibrillation Knowledge Scale (AF knowledge scale) will be used.", 
                "measure": "Patient knowledge", 
                "safety_issue": "No", 
                "time_frame": "After  1 year"
            }, 
            {
                "description": "This will be assessed by self-report using the Dutch version of the 8-item Morisky Medication Adherence Scale (MMAS-8 scale).", 
                "measure": "Patient adherence with medication", 
                "safety_issue": "No", 
                "time_frame": "After 1 year"
            }, 
            {
                "description": "This outcome will be searched for by reviewing medical records of, or by interviewing, all participating patients at 1, 3, 6 months and 1 year.", 
                "measure": "Time to establishment of a management plan by electrophysiologist or cardiologist", 
                "safety_issue": "No", 
                "time_frame": "After 1 year"
            }
        ], 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}